Klaviyo: Edward W. Hallen proposes $2.01M share sale
The proposed Series A sale is listed through Fidelity Brokerage Services LLC on NYSE.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Klaviyo, Inc. reports a proposed sale of 98,782 Series A shares for Edward W. Hallen’s account, with an aggregate market value of $2,005,274.60 and a proposed sale date of November 5, 2026. The notice identifies 59,615 shares from Hodgkins LLC and 39,167 from Hodgkins Trust; it describes Hallen as an authorized individual and account stakeholder for the LLC, and an account stakeholder for the trust.
Key Figures
Key Terms
Rule 144 regulatory
aggregate market value financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Which broker and exchange are listed for the proposed KVYO sale?
AI-generated analysis. How Rhea-AI works. Not financial advice.